Your browser doesn't support javascript.
loading
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez, Laura; Lamarca, Angela; La Casta, Adelaida; Buettner, Stefan; Utpatel, Kirsten; Klümpen, Heinz-Josef; Adeva, Jorge; Vogel, Arndt; Lleo, Ana; Fabris, Luca; Ponz-Sarvise, Mariano; Brustia, Raffaele; Cardinale, Vincenzo; Braconi, Chiara; Vidili, Gianpaolo; Jamieson, Nigel B; Macias, Rocio Ir; Jonas, Jan Philipp; Marzioni, Marco; Holówko, Waclaw; Folseraas, Trine; Kupcinskas, Juozas; Sparchez, Zeno; Krawczyk, Marcin; Krupa, Lukasz; Scripcariu, Viorel; Grazi, Gian Luca; Landa-Magdalena, Ana; Ijzermans, Jan Nm; Evert, Katja; Erdmann, Joris I; López-López, Flora; Saborowski, Anna; Scheiter, Alexander; Santos-Laso, Alvaro; Carpino, Guido; Andersen, Jesper B; Marin, Jose Jg; Alvaro, Domenico; Bujanda, Luis; Forner, Alejandro; Valle, Juan W; Koerkamp, Bas Groot; Banales, Jesus M.
Affiliation
  • Izquierdo-Sanchez L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases, CIBERehd, "Instituto de Salud Carlos III"
  • Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • La Casta A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Buettner S; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Utpatel K; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Klümpen HJ; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • Adeva J; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Lleo A; Division of Internal Medicine and Hepatology, Humanitas Clinical Research Center IRCSS, Humanitas University, Rozzano, Milan, Italy.
  • Fabris L; Department of Molecular Medicine (DMM), University of Padua School of Medicine, Padua, Italy; Digestive Disease Section, Yale University School of Medicine, New Haven, CT, USA.
  • Ponz-Sarvise M; Clinica Universidad de Navarra and Program in Solid Tumors (CIMA), Universidad de Navarra, IDISNA, Pamplona, Spain.
  • Brustia R; Department of Hepatobiliary and Liver Transplantation Surgery, AP-HP, Hôpital Pitié Salpêtrière, CRSA, Sorbonne Université, Paris, France.
  • Cardinale V; Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino "Sapienza" University of Rome, Latina, Italy.
  • Braconi C; Institute of Cancer Sciences, University of Glasgow, UK; The Royal Marsden NHS Trust, London & Surrey, UK.
  • Vidili G; Department of Medical, Surgical and Experimental Sciences, Clinica Medica Unit, University of Sassari, Azienda Ospedaliero-Universitaria di Sassari, Sassari, Italy.
  • Jamieson NB; Institute of Cancer Sciences, University of Glasgow, UK; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.
  • Macias RI; National Institute for the Study of Liver and Gastrointestinal Diseases, CIBERehd, "Instituto de Salud Carlos III" (ISCIII), Madrid, Spain; Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, Biomedical Research Institute (IBSAL), Salamanca, Spain.
  • Jonas JP; University Hospital Zurich, Department of Visceral- and Transplant Surgery, Zurich, Switzerland; Clinic Favoriten, Department for Surgery, Wien, Austria.
  • Marzioni M; Università Politecnica delle Marche, Department of Gastroenterology, Ancona, Italy.
  • Holówko W; Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Poland.
  • Folseraas T; Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and
  • Kupcinskas J; Department of Gastroenterology and Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Sparchez Z; 3rd Medical Department, Institute for Gastroenterology and Hepatology, University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Krawczyk M; Department of Medicine II Saarland University Medical Center, Saarland University, Homburg, Germany; Laboratory of Metabolic Liver Diseases, Center for Preclinical Research, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
  • Krupa L; Department of Gastroenterology and Hepatology with Internal Disease Unit, Teaching Hospital No 1 in Rzeszów, Poland; Medical Department, University of Rzeszów, Poland.
  • Scripcariu V; Department of Morpho-Functional Sciences I, Department of Surgery II, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
  • Grazi GL; Regina Elena National Cancer Institute, Rome, Italy.
  • Landa-Magdalena A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Ijzermans JN; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Evert K; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Erdmann JI; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • López-López F; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Saborowski A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Scheiter A; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Santos-Laso A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Carpino G; Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.
  • Andersen JB; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Marin JJ; National Institute for the Study of Liver and Gastrointestinal Diseases, CIBERehd, "Instituto de Salud Carlos III" (ISCIII), Madrid, Spain; Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, Biomedical Research Institute (IBSAL), Salamanca, Spain.
  • Alvaro D; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Bujanda L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases, CIBERehd, "Instituto de Salud Carlos III"
  • Forner A; National Institute for the Study of Liver and Gastrointestinal Diseases, CIBERehd, "Instituto de Salud Carlos III" (ISCIII), Madrid, Spain; Liver Unit. Barcelona Clinic Liver Cancer (BCLC) group. Hospital Clinic Barcelona. IDIBAPS. University of Barcelona, Spain.
  • Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Koerkamp BG; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases, CIBERehd, "Instituto de Salud Carlos III"
J Hepatol ; 76(5): 1109-1121, 2022 05.
Article in En | MEDLINE | ID: mdl-35167909
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article